Discovery and SAR of novel 4-thiazolyl-2-phenylaminopyrimidines as potent inhibitors of spleen tyrosine kinase (SYK)

被引：27

作者：

Farmer, Luc J. ^{[1
]}

Bemis, Guy ^{[1
]}

Britt, Shawn D. ^{[1
]}

Cochran, John ^{[1
]}

Connors, Martin ^{[1
]}

Harrington, Edmund M. ^{[1
]}

Hoock, Thomas ^{[1
]}

Markland, William ^{[1
]}

Nanthakumar, Suganthini ^{[1
]}

Taslimi, Paul ^{[1
]}

Ter Haar, Ernst ^{[1
]}

Wang, Jian ^{[1
]}

Zhaveri, Darshana ^{[1
]}

Salituro, Francesco G. ^{[1
]}

机构：

[1] Vertex Pharmaceut Inc, Dept Med Chem, Cambridge, MA 02139 USA

来源：

BIOORGANIC & MEDICINAL CHEMISTRY LETTERS | 2008年 / 18卷 / 23期

关键词：

SYK; Spleen tyrosine kinase; Asthma;

D O I：

10.1016/j.bmcl.2008.09.106

中图分类号：

R914 [药物化学];

学科分类号：

100701 ;

摘要：

A series of SYK inhibitors based on the phenylamino pyrimidine thiazole lead 4 were prepared and evaluated for biological activity. Lead optimization provided compounds with nanomolar K-i's against SYK and potent inhibition in mast cell degranulation assays. (C) 2008 Elsevier Ltd. All rights reserved.

引用

页码：6231 / 6235

页数：5

共 50 条

[31] Imidazotriazines: Spleen Tyrosine Kinase (Syk) Inhibitors Identified by Free-Energy Perturbation (FEP)
Lovering, Frank
Aevazelis, Cristina
Chang, Jeanne
Dehnhardt, Christoph
Fitz, Lori
Han, Seungil
Janz, Kristin
Lee, Julie
Kaila, Neelu
McDonald, Joseph
Moore, William
Moretto, Alessandro
Papaioannou, Nikolaos
Richard, David
Ryan, Mark S.
Wan, Zhao-Kui
Thorarensen, Atli
CHEMMEDCHEM, 2016, 11 (02) : 217 - 233
[32] Spleen tyrosine kinase inhibitors-novel therapies for RA?
Gomez-Puerta, Jose A.
Bosch, Xavier
NATURE REVIEWS RHEUMATOLOGY, 2011, 7 (03) : 134 - 136
[33] Spleen tyrosine kinase (Syk), a novel target of curcumin, is required for B lymphoma growth
Gururajan, Murali
Dasu, Trivikram
Shahidain, Seif
Jennings, C. Darrell
Robertson, Darrell A.
Rangnekar, Vivek M.
Bondada, Subbarao
JOURNAL OF IMMUNOLOGY, 2007, 178 (01): : 111 - 121
[34] Identification of pyrazolopyridine derivatives as novel spleen tyrosine kinase inhibitors
Huang, Yahui
Li, Yu
Dong, Guoqiang
Zhang, Wannian
Liu, Na
Sheng, Chunquan
ARCHIV DER PHARMAZIE, 2018, 351 (08)
[35] Discovery of potent and selective reversible Bruton?s tyrosine kinase inhibitors
Qiu, Hui
Ali, Zahid
Bender, Andrew
Caldwell, Richard
Chen, Yi-Ying
Fang, Zhizhou
Gardberg, Anna
Glaser, Nina
Goettsche, Anja
Goutopoulos, Andreas
Grenningloh, Roland
Hanschke, Bettina
Head, Jared
Johnson, Theresa
Jones, Christopher
Jones, Reinaldo
Kulkarni, Shashank
Maurer, Christine
Morandi, Federica
Neagu, Constantin
Poetzsch, Sven
Potnick, Justin
Schmidt, Ralf
Roe, Katherine
Follis, Ariele Viacava
Wing, Carolyn
Zhu, Xiaohua
Sherer, Brian
BIOORGANIC & MEDICINAL CHEMISTRY, 2021, 40
[36] Selective, novel spleen tyrosine kinase (Syk) inhibitors suppress chronic lymphocytic leukemia B-cell activation and migration
J Hoellenriegel
G P Coffey
U Sinha
A Pandey
M Sivina
A Ferrajoli
F Ravandi
W G Wierda
S O'Brien
M J Keating
J A Burger
Leukemia, 2012, 26 : 1576 - 1583
[37] Selective, novel spleen tyrosine kinase (Syk) inhibitors suppress chronic lymphocytic leukemia B-cell activation and migration
Hoellenriegel, J.
Coffey, G. P.
Sinha, U.
Pandey, A.
Sivina, M.
Ferrajoli, A.
Ravandi, F.
Wierda, W. G.
O'Brien, S.
Keating, M. J.
Burger, J. A.
LEUKEMIA, 2012, 26 (07) : 1576 - 1583
[38] Discovery and SAR of 1,3,4-thiadiazole derivatives as potent Abl tyrosine kinase inhibitors and cytodifferentiating agents
Radi, Marco
Crespan, Emmanuele
Botta, Giorgia
Falchi, Federico
Maga, Giovanni
Manetti, Fabrizio
Corradi, Valentina
Mancini, Manuela
Santucci, Maria Alessandra
Schenone, Silvia
Botta, Maurizio
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2008, 18 (03) : 1207 - 1211
[39] Furopyridines, discovery of a novel, potent, and selective class of spleen tyrosine kinase inhibitors with in vivo efficacy in a mouse collagen antibody-induced arthritis model
Burgdorf, Lars Thore
Ross, Tatjana
Deutsch, Carl
Hodous, Brian
Potnick, Justin
Bruns, Lisa
Grenningloh, Roland
Ji, Hong
Camps, Montserrat
Zimmerli, Simone
Rohdich, Felix
Greiner, Hartmut
Shutes, Adam
Kuhn, Daniel
Graedler, Ulrich
ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2013, 246
[40] Novel Substituted Quinazolines for Potent EGFR Tyrosine Kinase Inhibitors
Cruz-Lopez, O.
Conejo-Garcia, A.
Nunez, M. C.
Kimatrai, M.
Garcia-Rubino, M. E.
Morales, F.
Gomez-Perez, V.
Campos, J. M.
CURRENT MEDICINAL CHEMISTRY, 2011, 18 (07) : 943 - 963

← 1 2 3 4 5 →